Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2021 | 03-2020 | 03-2019 | 03-2018 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,193 | 1,132 | 2,278 | 7,179 | 10,595 |
| Receivables | 3,496 | 4,107 | 1,322 | 676 | 934 |
| Inventories | 5,013 | 4,143 | 4,516 | 4,898 | 6,416 |
| TOTAL | $12,195 | $10,251 | $8,857 | $13,702 | $18,413 |
| Non-Current Assets | |||||
| PPE Net | 6,649 | 7,228 | 8,444 | 8,994 | 9,039 |
| Intangibles | 6,634 | 6,634 | 6,634 | 7,713 | 6,419 |
| Other Non-Current Assets | 711 | 844 | 468 | 474 | 440 |
| TOTAL | $13,995 | $14,705 | $15,545 | $17,180 | $15,898 |
| Total Assets | $26,190 | $24,957 | $24,402 | $30,883 | $34,311 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 411 | 652 | 654 | 655 | 487 |
| Accounts payable and accrued liabilities | 930 | 1,578 | 1,375 | 1,658 | 1,050 |
| Accrued Expenses | 4,271 | 4,821 | 3,714 | 1,789 | 795 |
| Other current liabilities | N/A | N/A | 150 | N/A | N/A |
| TOTAL | $5,813 | $8,640 | $6,906 | $5,115 | $3,345 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,741 | 1,800 | 3,327 | 3,331 | 2,162 |
| Deferred Revenues | 13 | 180 | 1,013 | 1,013 | 1,013 |
| Other Non-Current Liabilities | 2,439 | 3,802 | 16,438 | 16,613 | 875 |
| TOTAL | $4,225 | $5,661 | $20,004 | $21,196 | $5,302 |
| Total Liabilities | $10,038 | $14,301 | $26,910 | $26,311 | $8,647 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,009,177 | 840,404 | 828,389 | 803,639 | 775,555 |
| Common Shares | 1,009 | 841 | 825 | 803 | 928 |
| Retained earnings | -148,958 | -154,046 | -151,806 | -142,527 | -138,854 |
| Other shareholders' equity | -307 | 13,597 | -307 | -307 | -307 |
| TOTAL | $16,152 | $10,656 | $-2,508 | $4,572 | $25,664 |
| Total Liabilities And Equity | $26,190 | $24,957 | $24,402 | $30,883 | $34,311 |